These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11300866)

  • 41. Microsomal transfer protein inhibition in humans.
    Cuchel M; Rader DJ
    Curr Opin Lipidol; 2013 Jun; 24(3):246-50. PubMed ID: 23594709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lysine and arginine residues in the N-terminal 18% of apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein.
    Bakillah A; Jamil H; Hussain MM
    Biochemistry; 1998 Mar; 37(11):3727-34. PubMed ID: 9521691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species.
    Ugawa T; Kakuta H; Moritani H; Matsuda K; Ishihara T; Yamaguchi M; Naganuma S; Iizumi Y; Shikama H
    Br J Pharmacol; 2000 Sep; 131(1):63-70. PubMed ID: 10960070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonist.
    Bakillah A; Nayak N; Saxena U; Medford RM; Hussain MM
    Biochemistry; 2000 Apr; 39(16):4892-9. PubMed ID: 10769147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311).
    Qiao JX; Wang TC; Adam LP; Chen AY; Taylor DS; Yang RZ; Zhuang S; Sleph PG; Li JP; Li D; Yin X; Chang M; Chen XQ; Shen H; Li J; Smith D; Wu DR; Leith L; Harikrishnan LS; Kamau MG; Miller MM; Bilder D; Rampulla R; Li YX; Xu C; Lawrence RM; Poss MA; Levesque P; Gordon DA; Huang CS; Finlay HJ; Wexler RR; Salvati ME
    J Med Chem; 2015 Nov; 58(22):9010-26. PubMed ID: 26524347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
    Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis and in vivo screening of some novel quinazoline analogs as anti-hyperlipidemic and hypoglycemic agents.
    Mokale SN; Palkar AD; Dube PN; Sakle NS; Miniyar PB
    Bioorg Med Chem Lett; 2016 Jan; 26(2):272-276. PubMed ID: 26707395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
    Tooulia KK; Theodosis-Nobelos P; Rekka EA
    Arch Pharm (Weinheim); 2015 Sep; 348(9):629-34. PubMed ID: 26191791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lomitapide.
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):347-52. PubMed ID: 21846156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes.
    Gleeson A; Anderton K; Owens D; Bennett A; Collins P; Johnson A; White D; Tomkin GH
    Diabetologia; 1999 Aug; 42(8):944-8. PubMed ID: 10491754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid regression of atherosclerosis with MTP inhibitor treatment.
    Hewing B; Parathath S; Mai CK; Fiel MI; Guo L; Fisher EA
    Atherosclerosis; 2013 Mar; 227(1):125-9. PubMed ID: 23332773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity.
    Trivedi BK; Purchase TS; Holmes A; Augelli-Szafran CE; Essenburg AD; Hamelehle KL; Stanfield RL; Bousley RF; Krause BR
    J Med Chem; 1994 May; 37(11):1652-9. PubMed ID: 8201599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and biological evaluation of quinuclidine derivatives incorporating phenothiazine moieties as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2004 Oct; 52(10):1204-9. PubMed ID: 15467236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity.
    Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E
    Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and hypolipidemic activity of 4-substituted 1-acyl-1,2,4-triazolidine-3,5-diones in rodents.
    Simlot R; Izydore RA; Wong OT; Hall IH
    J Pharm Sci; 1993 Apr; 82(4):408-15. PubMed ID: 8468686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 2-Azetidinone cholesterol absorption inhibitors: increased potency by substitution of the C-4 phenyl ring.
    Vaccaro WD; Sher R; Davis HR
    Bioorg Med Chem; 1998 Sep; 6(9):1429-37. PubMed ID: 9801814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thiourea-based gemfibrozil analogues as HDL-elevating agents.
    Coppola GM; Damon RE; Eskesen JB; France DS; Paterniti JR
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2439-42. PubMed ID: 12161152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypolipidemic activity of substituted 2-pyrrolidinones in rodents.
    Cocolas GH; Chapman JM; Voorstad PJ; Hall IH
    J Pharm Sci; 1983 Jul; 72(7):812-4. PubMed ID: 6886988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.